Ionis Pharmaceuticals (NASDAQ:IONS) Receives Buy Rating from Needham & Company LLC
Needham & Company LLC restated their buy rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a research report report published on Friday...
DICK’S Sporting Goods (NYSE:DKS) Coverage Initiated at Truist Financial
Truist Financial started coverage on shares of DICK’S Sporting Goods (NYSE:DKS – Free Report) in a research report released on Friday, MarketBeat Ratings reports. The...
Bath & Body Works (NYSE:BBWI) PT Lowered to $42.00
Bath & Body Works (NYSE:BBWI – Free Report) had its target price reduced by Telsey Advisory Group from $52.00 to $42.00 in a research report...
JPMorgan Chase & Co. Raises Applied Materials (NASDAQ:AMAT) Price Target to $170.00
Applied Materials (NASDAQ:AMAT – Free Report) had its target price upped by JPMorgan Chase & Co. from $165.00 to $170.00 in a research report sent...
ADTRAN (NASDAQ:ADTN) Upgraded by StockNews.com to Sell
StockNews.com upgraded shares of ADTRAN (NASDAQ:ADTN – Free Report) to a sell rating in a research report released on Friday morning. Several other brokerages have...
Akebia Therapeutics (NASDAQ:AKBA) Price Target Increased to $5.00 by Analysts at HC Wainwright
Akebia Therapeutics (NASDAQ:AKBA – Free Report) had its price objective hoisted by HC Wainwright from $3.75 to $5.00 in a research report report published on...